Ultrasounds can help identify pneumonia and its progression in children without exposure to ionizing radiation.
Lung ultrasonography (LUS) can help identify and follow progress of pneumonia in children, according to an article published in the journal Pediatrics & Neonatology.
Researchers from Taiwan performed a retrospective study to determine if LUS would be an effective tool in diagnosing pediatric pneumonia. A total of 163 children (mean age 73.2 months) were enrolled in the study. All patients underwent chest radiography as well as LUS. LUS was also used to follow 23 of the patients during the progression of their illness.
The results showed a detection rate of 0.93 for radiography and 0.98 for LUS. Of the 163 patients, chest radiography identified pneumonia in 152 patients and LUS detected pneumonia in 159 patients. Four patients had pneumonia detected by radiography and not LUS, while 12 patients showed no pneumonia according to radiography but had lesions detected by LUS.
The LUS also tracked the progress of 23 patients:
The authors concluded that the LUS showed a high detection rate in identifying pneumonia among children. “We suggest that LUS is a complementary tool to chest radiography in the diagnosis of pneumonia in children and that the follow-up of patients with pneumonia by LUS can reduce the exposure of children to ionizing radiation,” they wrote.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
November 14th 2024Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.